Viewing Study NCT04034459


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2025-12-27 @ 10:09 AM
Study NCT ID: NCT04034459
Status: UNKNOWN
Last Update Posted: 2023-11-14
First Post: 2017-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC
Sponsor: Ludwig-Maximilians - University of Munich
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module